Wayne J Morgan

Author PubWeight™ 122.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010 6.51
2 Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006 6.10
3 Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011 5.61
4 Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet 2011 5.42
5 Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005 4.50
6 Daily or intermittent budesonide in preschool children with recurrent wheezing. N Engl J Med 2011 4.09
7 Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008 4.06
8 Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007 3.49
9 Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol 2003 3.41
10 Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidity. J Allergy Clin Immunol 2005 3.38
11 Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 2007 3.22
12 Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol 2004 2.80
13 Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2006 2.79
14 Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet 2008 2.70
15 Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol 2008 2.56
16 Cost-effectiveness of a home-based environmental intervention for inner-city children with asthma. J Allergy Clin Immunol 2005 2.22
17 Clinical screening of school children for polysomnography to detect sleep-disordered breathing--the Tucson Children's Assessment of Sleep Apnea study (TuCASA). J Clin Sleep Med 2005 2.21
18 Persistence of asthma symptoms during adolescence: role of obesity and age at the onset of puberty. Am J Respir Crit Care Med 2004 2.20
19 Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 2006 2.02
20 Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 2003 1.97
21 The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network. Control Clin Trials 2004 1.79
22 Pulmonary outcome prediction (POP) tools for cystic fibrosis patients. Pediatr Pulmonol 2010 1.71
23 Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol 2007 1.67
24 Asthma control, adiposity, and adipokines among inner-city adolescents. J Allergy Clin Immunol 2010 1.63
25 Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis. J Pediatr 2008 1.60
26 Effect of breastfeeding on lung function in childhood and modulation by maternal asthma and atopy. Am J Respir Crit Care Med 2007 1.59
27 Risk of current asthma among adult smokers with respiratory syncytial virus illnesses in early life. Am J Respir Crit Care Med 2014 1.54
28 Clinical outcomes associated with sleep-disordered breathing in Caucasian and Hispanic children--the Tucson Children's Assessment of Sleep Apnea study (TuCASA). Sleep 2003 1.48
29 Learning in children and sleep disordered breathing: findings of the Tucson Children's Assessment of Sleep Apnea (tuCASA) prospective cohort study. J Int Neuropsychol Soc 2003 1.27
30 Symptoms related to sleep-disordered breathing in white and Hispanic children: the Tucson Children's Assessment of Sleep Apnea Study. Chest 2003 1.24
31 Airborne fungi in the homes of children with asthma in low-income urban communities: The Inner-City Asthma Study. J Allergy Clin Immunol 2004 1.24
32 Asthma outcomes workshop: overview. J Allergy Clin Immunol 2012 1.22
33 Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. J Allergy Clin Immunol 2009 1.21
34 A randomized clinical trial of clinician feedback to improve quality of care for inner-city children with asthma. Pediatrics 2006 1.12
35 Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescents. J Allergy Clin Immunol 2012 1.12
36 Lower airway obstruction is associated with increased morbidity in children with sickle cell disease. Pediatr Pulmonol 2009 1.06
37 Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis. Pediatr Pulmonol 2011 1.06
38 Behavior problems associated with sleep disordered breathing in school-aged children--the Tucson children's assessment of sleep apnea study. J Pediatr Psychol 2005 1.02
39 Differential effects of outdoor versus indoor fungal spores on asthma morbidity in inner-city children. J Allergy Clin Immunol 2010 1.01
40 Year-to-year changes in lung function in individuals with cystic fibrosis. J Cyst Fibros 2010 1.00
41 Trends in the use of routine therapies in cystic fibrosis: 1995-2005. Pediatr Pulmonol 2010 1.00
42 Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescents. Am J Clin Nutr 2013 1.00
43 Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with cystic fibrosis. J Pediatr 2011 0.99
44 Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J Allergy Clin Immunol 2008 0.98
45 Impact of pregnancy on women with cystic fibrosis. Chest 2006 0.97
46 Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005. Pediatr Pulmonol 2008 0.97
47 Risk factors for rate of decline in FEV1 in adults with cystic fibrosis. J Cyst Fibros 2012 0.97
48 Sleep architecture in normal Caucasian and Hispanic children aged 6-11 years recorded during unattended home polysomnography: experience from the Tucson Children's Assessment of Sleep Apnea Study (TuCASA). Sleep Med 2003 0.96
49 Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function. Pediatrics 2007 0.95
50 Lung function decline from adolescence to young adulthood in cystic fibrosis. Pediatr Pulmonol 2011 0.95
51 Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 2012 0.92
52 Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis. J Cyst Fibros 2012 0.92
53 Long-term outcomes of early-onset wheeze and asthma. J Allergy Clin Immunol 2012 0.90
54 Parasomnias and sleep disordered breathing in Caucasian and Hispanic children - the Tucson children's assessment of sleep apnea study. BMC Med 2004 0.89
55 Comparison between reported and recorded total sleep time and sleep latency in 6- to 11-year-old children: the Tucson Children's Assessment of Sleep Apnea Study (TuCASA). Sleep Breath 2007 0.89
56 Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms. Pediatr Pulmonol 2012 0.88
57 Combined effects of parental and active smoking on early lung function deficits: a prospective study from birth to age 26 years. Thorax 2013 0.87
58 Relationship between infant weight gain and later asthma. Pediatr Allergy Immunol 2009 0.87
59 Changing thresholds and incidence of antibiotic treatment of cystic fibrosis pulmonary exacerbations, 1995-2005. J Cyst Fibros 2012 0.86
60 Lymphoscintigraphy in plastic bronchitis, a pediatric case report. Pediatr Pulmonol 2012 0.86
61 Genetic variation in vascular endothelial growth factor-a and lung function. Am J Respir Crit Care Med 2012 0.86
62 Impaired lung diffusing capacity for nitric oxide and alveolar-capillary membrane conductance results in oxygen desaturation during exercise in patients with cystic fibrosis. J Cyst Fibros 2010 0.85
63 Early childhood wheezing is associated with lower lung function in cystic fibrosis. Pediatr Pulmonol 2013 0.83
64 Ventilatory drive and the apnea-hypopnea index in six-to-twelve year old children. BMC Pulm Med 2004 0.83
65 Genetic variation of SCNN1A influences lung diffusing capacity in cystic fibrosis. Med Sci Sports Exerc 2012 0.82
66 Relation of early childhood growth and wheezing phenotypes to adult lung function. Pediatr Pulmonol 2011 0.79
67 Relation of beta2-adrenoceptor polymorphisms at codons 16 and 27 to persistence of asthma symptoms after the onset of puberty. Chest 2005 0.78
68 The outcomes of sickle cell disease in adulthood are clear, but the origins and progression of sickle cell anemia-induced problems in the heart and lung in childhood are not. J Pediatr 2006 0.78
69 Clinical use of tobramycin inhalation solution (TOBI®) shows sustained improvement in FEV1 in cystic fibrosis. Pediatr Pulmonol 2013 0.77
70 Predictors of specific airway resistance during childhood. Am J Respir Crit Care Med 2014 0.75
71 Influence of genetic variation of the β2-adrenergic receptor on lung diffusion in patients with cystic fibrosis. Pulm Pharmacol Ther 2011 0.75
72 Liver involvement in the Hispanic population of North America with cystic fibrosis. J Pediatr Gastroenterol Nutr 2014 0.75